Discover the subtle warning signs of metastatic cancer that are often overlooked. Learn how early detection of cancer spread ...

Under terms of the deal, Pfizer will gain rights to develop, manufacture, and commercialize SSGJ-707 outside of China.

Metastatic colorectal cancer (mCRC) continues to pose a clinical and commercial challenge, with low 5-year survival rates and limited durable respons ...

As scientists question the rise in early colon cancer cases, a new study is offering some potential answers. Colored scanning ...

Colon cancer is the third most common cancer in males * Oral cavity bacteria are responsible for the progression of colon ...

Pfizer (NYSE:PFE) has signed an exclusive global licensing deal with China’s 3SBio for the development of its cancer drug ...

The findings will be presented at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)• Dana-Farber ...

Pfizer Inc. announced Monday it has secured exclusive global rights, excluding China, to 3SBio Inc.'s bispecific antibody ...